GILLETTE CHILDREN'S SPECIALTY HEALTHCARE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Effects of Cannabidiol (CBD) on Electrical and Autonomic Cardiac Function in Children With Severe Epilepsy

Phase 1

Terminated

Conditions: Lennox-Gastaut Syndrome
Dravet Syndrome

Interventions: Procedure: 12-Lead ECG
Drug: Cannabidiol

First Posted Date: 2016-06-28

Last Posted Date: 2022-08-30

Lead Sponsor: Gillette Children's Specialty Healthcare

Target Recruit Count: 2

Registration Number: NCT02815540

Locations: 🇺🇸
Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States

Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions

Not Applicable

Completed

Conditions: Rett Syndrome
Spinal Muscular Atrophy
Cerebral Palsy
Osteopenia
Muscular Dystrophy
Spina Bifida

Interventions: Other: Assisted Standing Treatment Program

First Posted Date: 2015-04-29

Last Posted Date: 2021-02-21

Lead Sponsor: Gillette Children's Specialty Healthcare

Target Recruit Count: 6

Registration Number: NCT02428673

Locations: 🇺🇸
Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States

Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy

Not Applicable

Completed

Conditions: Spinal Muscular Dystrophy
Neuromuscular Disability

Interventions: Other: Assisted Standing Treatment Program

First Posted Date: 2015-01-19

Last Posted Date: 2021-02-17

Lead Sponsor: Gillette Children's Specialty Healthcare

Target Recruit Count: 4

Registration Number: NCT02341053

Locations: 🇺🇸
Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States

Load Experienced While Using a Stander in Children With Cerebral Palsy

Not Applicable

Completed

Conditions: Cerebral Palsy

Interventions: Other: Assisted Standing Treatment Program

First Posted Date: 2013-09-30

Last Posted Date: 2016-02-17

Lead Sponsor: Gillette Children's Specialty Healthcare

Target Recruit Count: 3

Registration Number: NCT01952496

Locations: 🇺🇸
Clinical and Translational Science Institute at University of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Gillette Children's Specialty Healthcare, St. Paul, Minnesota, United States

Gentamicin Bladder Instillation Trial

Phase 4

Conditions: Urinary Tract Infections

Interventions: Drug: Placebo
Drug: Gentamicin

First Posted Date: 2013-06-24

Last Posted Date: 2015-04-09

Lead Sponsor: Gillette Children's Specialty Healthcare

Target Recruit Count: 24

Registration Number: NCT01884467

Locations: 🇺🇸
Gillette Lifetime Specialty Healthcare, Saint Paul, Minnesota, United States

Effectiveness of Gabapentin on Chronic Irritability in Neurologically Impaired Children

Phase 2

Terminated

Conditions: Sleeplessness
Neurologically Impaired
Signs and Symptoms, Digestive
Irritable Mood
Chronic Pain

Interventions: Drug: Gabapentin
Drug: placebo

First Posted Date: 2012-08-30

Last Posted Date: 2019-08-02

Lead Sponsor: Gillette Children's Specialty Healthcare

Target Recruit Count: 2

Registration Number: NCT01675960

Locations: 🇺🇸
Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Phase 2

Completed

Conditions: Dravet Syndrome

Interventions: Drug: Verapamil

First Posted Date: 2012-05-28

Last Posted Date: 2021-04-13

Lead Sponsor: Gillette Children's Specialty Healthcare

Target Recruit Count: 2

Registration Number: NCT01607073

Locations: 🇺🇸
Gillette Children's Specialty Healthcare, Saint Paul, Minnesota, United States
🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Children's Memorial Hospital, Chicago, Illinois, United States

and more 1 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy